ID   EGFP-K562
AC   CVCL_1G55
DR   BEI_Resources; ARP-11699
DR   Wikidata; Q54832084
RX   PubMed=12505723;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
RX   PubMed=12505723; DOI=10.1016/S0022-1759(02)00505-7;
RA   Kantakamalakul W., Jaroenpool J., Pattanapanyasat K.;
RT   "A novel enhanced green fluorescent protein (EGFP)-K562 flow
RT   cytometric method for measuring natural killer (NK) cell cytotoxic
RT   activity.";
RL   J. Immunol. Methods 272:189-197(2003).
//